Stockscreener 앱 받기
3.57
2.19%
-0.08
시간 외 거래:
3.57
Adc Therapeutics Sa 주식(ADCT)의 최신 뉴스
ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook - TipRanks
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates - PR Newswire
Can ADC Therapeutics SA stock rebound after recent weaknessMarket Activity Report & Weekly Watchlist of Top Performers - ulpravda.ru
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Nasdaq
ADC Therapeutics SA Common Shares (NY: ADCT - markets.financialcontent.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - FinancialContent
Will ADC Therapeutics SA stock outperform international peers2026 world cup usa national team round of 32 top scorers high defensive line tactical prediction guide - ulpravda.ru
ADCT stock touches 52-week low at $1.42 amid market challenges - MSN
ADC Therapeutics Announces New Employee Inducement Grant - 富途牛牛
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Graphic Packaging Holding Company - GlobeNewswire Inc.
ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why - Yahoo Finance
Is ADC Therapeutics SA a good long term investmentOptions Trading Strategies & Free Take Advantage Of Momentum - earlytimes.in
Corient Private Wealth LLC Makes New Investment in ADC Therapeutics SA $ADCT - MarketBeat
Risk Report: Will ADC Therapeutics SA stock beat EPS estimatesQuarterly Profit Report & Fast Gaining Stock Reports - Улправда
How geopolitical tensions affect ADC Therapeutics SA stockJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - Улправда
Can ADC Therapeutics SA Common Shares stock sustain margin levelsTrade Risk Assessment & Real-Time Stock Entry Alerts - Улправда
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - marketscreener.com
Is ADC Therapeutics SA stock a contrarian buyJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - Улправда
ADC Therapeutics SA (NYSE:ADCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Will ADC Therapeutics SA stock beat EPS estimatesMarket Activity Report & Safe Entry Zone Identification - Улправда
Is ADC Therapeutics SA Common Shares stock testing key supportJuly 2025 WrapUp & Weekly Stock Breakout Alerts - Улправда
Wall Street Recap: Is ADC Therapeutics SA Common Shares stock undervalued historically2025 EndofYear Setup & Weekly High Return Forecasts - Улправда
How buybacks impact ADC Therapeutics SA stock value2025 Investor Takeaways & Entry and Exit Point Strategies - Улправда
Is ADC Therapeutics SA Common Shares stock undervalued historically2025 Big Picture & Weekly Momentum Stock Picks - Улправда
RBC Capital Bullish on ADC Therapeutics S.A. (ADCT) on Lymphoma Treatment Development - Yahoo Finance
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year? - sharewise.com
ADC Therapeutics (NYSE:ADCT) Sees Large Volume IncreaseStill a Buy? - MarketBeat
ADC Therapeutics SA (ADCT) is a Great Momentum Stock: Should You Buy? - sharewise.com
ADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call Transcript - MSN
ADC Therapeutics SA Stock Analysis and ForecastHigh Beta Stocks & Predict Price Movements With AI Precision - earlytimes.in
CEO Mallik Surrenders 233,146 Of ADC Therapeutics SA [ADCT] - TradingView — Track All Markets
Officer Graham Surrenders 49,508 Of ADC Therapeutics SA [ADCT] - TradingView — Track All Markets
ADC Therapeutics (NYSE: ADCT) CEO reports 233,146-share tax withholding - Stock Titan
ADC Therapeutics (ADCT) CMO has 41,068 shares withheld for RSU taxes - Stock Titan
ADC Therapeutics (ADCT) CAO reports 7,140 shares withheld for RSU tax and holds 70,757 - Stock Titan
ADC Therapeutics (ADCT) CLO Peter Graham reports tax share withholding - Stock Titan
ADC Therapeutics (ADCT) CFO reports 53,236-share tax withholding from RSU vesting - Stock Titan
ADC Therapeutics (ADCT) files S-3/A Amendment No. 1 to add new auditor consent - Stock Titan
Adc Therapeutics SA (ADCT) expanding its growth trajectory ahead - setenews.com
ADC Therapeutics reports promising LOTIS-7 trial results - MSN
ADC Therapeutics Reports Promising LOTIS-7 Trial Results - TipRanks
ADC Therapeutics Updates LOTIS-7 Trial Data - TradingView — Track All Markets
[8-K] ADC Therapeutics SA Reports Material Event | ADCT SEC FilingForm 8-K - Stock Titan
Is ADC Therapeutics SA Common Shares stock attractive post correction2025 Institutional Moves & Growth Focused Investment Plans - Newser
Is ADC Therapeutics SA stock oversold or undervalued2025 Market WrapUp & Scalable Portfolio Growth Ideas - Newser
What momentum indicators show for ADC Therapeutics SA stockShare Buyback & Accurate Entry and Exit Point Alerts - Newser
Will ADC Therapeutics SA stock benefit from commodity pricesQuarterly Trade Summary & Daily Entry Point Alerts - Newser
0.80%
4.56%
자본화:
|
볼륨(24시간):